4/A: CareDx Director Peter Maag Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Filing (Form 4/A)
Peter Maag, a director at CareDx, Inc., filed an amendment to a Form 4 to correct the exercise price of a stock option.
Summary
- Peter Maag, a director of CareDx, Inc., filed an amended Form 4 with the SEC.
- The amendment corrects the exercise price of a stock option (right to buy) previously reported.
- The correct exercise price is $14.19.
- The original filing was made on June 18, 2024, and this amendment is dated June 20, 2024.
- Maag was granted options to buy 16,048 shares of CareDx common stock on June 14, 2024.
- The options vest monthly, starting July 14, 2024, and continuing through June 14, 2025, and expire on June 14, 2034.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The correction of the stock option exercise price ensures accurate information is available to shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the earliest transaction (grant of stock options) |
| 06/14/2024 | Date of stock option grant |
| 07/14/2024 | First vesting date for the stock options |
| 06/14/2025 | Last vesting date for the stock options |
| 06/14/2034 | Expiration date for the stock options |
| 06/18/2024 | Date of original Form 4 filing |
| 06/20/2024 | Date of amended Form 4/A filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.